3654 results for «600»
3654 results
Mixed VHD: how to manage?
11 Mar 2023 – From PCR Imaging Valves Madrid 2023
Consult this session to learn more about aortic stenosis and aortic regurgitation: how to diagnose these conditions, how to select patients for surgical or transcatheter interventions, and how to treat them.
Endocarditis: what can we suggest for the upcoming ESC guidelines?
11 Mar 2023 – From PCR Imaging Valves Madrid 2023
Watch this session to learn more about the various challenges in treating patients with endocarditis, to understand how to better diagnose valve endocarditis and to discover new transcatheter interventions after endocarditis.
The challenge of aortic regurgitation: better imaging for better clinical practice
10 Mar 2023 – From PCR Imaging Valves Madrid 2023
Watch this session to learn about the challenges of diagnosing aortic regurgitation and how to overcome them, to better understand the right timing for intervention based on available evidence, and to discover what tools exist to more accurately assess the severity of aortic regurgitation.
Imaging before and after TAVI - How to treat
10 Mar 2023 – From PCR Imaging Valves Madrid 2023
Consult this session on imaging before and after TAVI to learn how to better select patients for TAVI, to understand how to treat paravalvular leak and to know how to deal with and prevent valve thrombosis.
Where are we going? The symptomatic patient with moderate aortic stenosis
10 Mar 2023 – From PCR Imaging Valves Madrid 2023
Watch these presentations on symptomatic patient with moderate aortic stenosis to learn to evaluate outcomes after TAVI, to better assess aortic stenosis and LV function, and to expand your knowledge in infiltrative diseases.
Diagnosis of disease type and of disease severity
10 Mar 2023 – From PCR Imaging Valves Madrid 2023
Consult this session to learn how to better assess mitral regurgitation and how to better diagnose mitral stenosis through imaging.
CTO PCI in images and case examples: what is new in 2026?
07 Jul 2026
Register for free to this webinar on Monday 31 August at 6:00pm with K. Mashayekhi, M. Ayoub and C. Ungureanu and learn to review the recent evidence on expected outcomes after CTO PCI, and much more!
Primary Outcomes of a Pivotal Multicenter Randomized Trial Comparing the AGENT Paclitaxel-Coated Ballon with Conventional Ballon Angioplasty for In-Stent Restenosis (AGENT IDE)
27 Oct 2023
Mirvat Alasnag provides her take on the AGENT IDE trial which was presented by Robert W. Yeh at TCT Congress 2023. This pivotal randomized trial compares the safety and efficacy of the AGENT DCB to conventional balloon angioplasty in patients with ISR. It is the first...
Author
The greatest advance in the next 40 years would be to remove the need for angioplasty
17 May 2017
Spencer B. King performed some of the first coronary angioplasty procedures in the USA—having recently received a thank-you from the first patient that he treated. He tells The Daily Wire that the steerable guidewire, rather than the stent, was the greatest advance in angioplasty and that...
Authors :
ALL-RISE: A large-scale, global randomized trial of coronary physiology derived from conventional angiography compared with an invasive pressure wire-based approach to guide PCI
28 Mar 2026
Mirvat Al Asnag provides her take on the ALL-RISE randomised trial presented by Ajay J. Kirtane at ACC.26 in New Orleans.
Author
From PROTECT-AF to CHAMPION-AF: Where do we stand today?
01 Jul 2026
In this article, Jens Erik Nielsen-Kudsk reviews the evolution of left atrial appendage closure, from early trials such as PROTECT‑AF to recent evidence including CHAMPION‑AF, and discusses its expanding role in stroke prevention for atrial fibrillation.
Author
The AQUATIC trial: Assessment of quitting versus using aspirin therapy in patients with stabilized coronary artery disease after stenting who require long-term oral anticoagulation
01 Sep 2025
Chiara De Biase provides her take on the results of AQUATIC presented by Martine Gilard at ESC Congress 2025 in Madrid.
Author
![The AQUATIC trial [Assessment of quitting versus using aspirin therapy in patients with stabilized coronary artery disease after stenting who require long-term oral anticoagulation: Rationale for and design of the AQUATIC double-blind randomized trial]](https://www.pcronline.com/var/pcrov3/storage/images/pcronline/news/congress-coverages/esc/2025/aquatic-trial-quitting-versus-using-aspirin-therapy-patients-stabilized-cad-stenting-long-term-oral-anticoagulation/27448089-9-eng-GB/The-AQUATIC-trial-Assessment-of-quitting-versus-using-aspirin-therapy-in-patients-with-stabilized-coronary-artery-disease-after-stenting-who-requi_image_responsive_6.jpg)
A randomized, placebo-controlled trial of chronic total occlusion PCI in stable angina - ORBITA-CTO trial
03 Apr 2026
Kalaivani Mahadevan provides an in-depth analysis of the ORBITA-CTO trial: a first-ever randomised, double-blind, placebo-controlled trial evaluating CTO PCI in stable angina patients.
She also interviewed principal investigators Sarosh Khan and John Davies following the LBCT Scientific Session at ACC.26 in New Orleans and simultaneous publication in...
Author
Author
Author
COVID-19 vaccines: Burning questions from the community and real-world applicability
13 Jan 2021
View a number of questions of interest to the interventional cardiovascular community, as well as the real-world applicability of COVID-19 vaccine trials.
